Clinical Trials Browser

Has results × Carcinoma × Sorafenib × Clear all

NCT03755791 2025-12-11

COSMIC-312

Phase 3 Active not recruiting

837 enrolled 14 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT00576056 2017-02-15

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Phase 2 Terminated

19 enrolled 7 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT00941863 2016-03-22

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Phase 1 Completed

158 enrolled 17 charts

Carcinoma